TRUXIMA

Celltrion Inc🇨🇦 Health Canada

Approval Id: c48732b40ee6e60f
Drug Approval Canada Name: TRUXIMA
Product Name: TRUXIMA
Status: Marketed
Status Date: 2024-08-22
Original Market Date: 2019-12-11
Din: 02478382
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Intravenous
Schedule: Schedule D , Prescription
Ahfs: 10:00.00
Atc Original: L01FA01 RITUXIMAB
Atc Name: l 01 fa 01
Aig Number: 0140241001
Company Name: Celltrion Inc
Company Address: 23 Academy-Ro, Yeonsu-Gu, Incheon, --, Korea, Republic Of, 22014
Company Detail Path: /organization/celltrion-inc

RITUXIMAB

100 MG / 10 ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

c48732b40ee6e60f

Type

Standard